TNF and inflammatory bowel disease: Current therapeutic strategies for IBD include corticosteroids, aminosalicylates, anti-TNF-α agents and immunosuppressive drugs but these drugs are associated with serious adverse effects including kidney problems and hypersensitivity reactions (Minaiyan et al., 2014).